Nanoparticle-albumin-bound paclitaxel (nab-paclitaxel; Abraxane®) is a chemotherapeutic drug that is administered alone or in combination with other agents for the purpose of delaying disease progression and prolonging survival in patients who have cancer. Nab-paclitaxel differs from standard paclitaxel in that it is a colloidal suspension of 130-nanometer (nm) albumin-bound nanoparticles of paclitaxel and is, therefore, free of solvents. The goal of this new nanotechnology based formulation is to reduce toxicity and improve the bioavailability of paclitaxel.